1. Home
  2. MX vs ACET Comparison

MX vs ACET Comparison

Compare MX & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magnachip Semiconductor Corporation

MX

Magnachip Semiconductor Corporation

HOLD

Current Price

$3.49

Market Cap

95.4M

Sector

Technology

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$8.01

Market Cap

77.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MX
ACET
Founded
2003
1947
Country
South Korea
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
95.4M
77.3M
IPO Year
2007
2017

Fundamental Metrics

Financial Performance
Metric
MX
ACET
Price
$3.49
$8.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$5.75
$48.33
AVG Volume (30 Days)
297.1K
141.6K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
43.06
N/A
EPS
N/A
N/A
Revenue
$178,860,000.00
N/A
Revenue This Year
$8.55
N/A
Revenue Next Year
$6.37
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.18
$0.46
52 Week High
$4.50
$9.05

Technical Indicators

Market Signals
Indicator
MX
ACET
Relative Strength Index (RSI) 74.73 60.07
Support Level $2.69 $7.70
Resistance Level $4.50 $8.34
Average True Range (ATR) 0.12 0.49
MACD 0.06 0.20
Stochastic Oscillator 91.07 74.45

Price Performance

Historical Comparison
MX
ACET

About MX Magnachip Semiconductor Corporation

MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely, Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

Share on Social Networks: